Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.53M Buy
18,009
+109
+0.6% +$23.5K 0.07% 93
2026
Q1
$3.89M Buy
17,900
+875
+5% +$194K 0.07% 93
2025
Q4
$3.89M Buy
17,025
+1,494
+10% +$340K 0.07% 93
2025
Q3
$3.6M Sell
15,531
-1,129
-7% -$230K 0.06% 97
2025
Q2
$3.09M Sell
16,660
-3,978
-19% -$739K 0.06% 106
2025
Q1
$4.32M Buy
20,638
+3,178
+18% +$618K 0.09% 95
2024
Q4
$3.1M Sell
17,460
-1,833
-10% -$337K 0.06% 108
2024
Q3
$3.81M Sell
19,293
-121
-0.6% -$22.6K 0.07% 102
2024
Q2
$3.33M Buy
19,414
+53
+0.3% +$8.78K 0.07% 101
2024
Q1
$3.53M Sell
19,361
-594
-3% -$102K 0.07% 100
2023
Q4
$3.09M Sell
19,955
-1,588
-7% -$232K 0.07% 105
2023
Q3
$3.21M Sell
21,543
-1,516
-7% -$223K 0.08% 111
2023
Q2
$3.11M Buy
23,059
+840
+4% +$123K 0.07% 113
2023
Q1
$3.54M Sell
22,219
-1,237
-5% -$189K 0.09% 109
2022
Q4
$3.79M Sell
23,456
-150
-0.6% -$23K 0.1% 106
2022
Q3
$3.17M Sell
23,606
-1,563
-6% -$224K 0.09% 109
2022
Q2
$3.85M Buy
25,169
+546
+2% +$83.4K 0.11% 106
2022
Q1
$3.99M Buy
24,623
+3,691
+18% +$536K 0.1% 109
2021
Q4
$2.83M Sell
20,932
-60
-0.3% -$7.09K 0.06% 115
2021
Q3
$2.26M Sell
20,992
-329
-2% -$37.6K 0.06% 116
2021
Q2
$2.4M Buy
21,321
+669
+3% +$75.3K 0.06% 112
2021
Q1
$2.23M Sell
20,652
-445
-2% -$47.6K 0.06% 115
2020
Q4
$2.26M Buy
21,097
+2,761
+15% +$265K 0.06% 111
2020
Q3
$1.61M Buy
18,336
+977
+6% +$92K 0.05% 119
2020
Q2
$1.7M Sell
17,359
-112
-0.6% -$9.86K 0.06% 116
2020
Q1
$1.33M Sell
17,471
-1,643
-9% -$140K 0.06% 117
2019
Q4
$1.69M Sell
19,114
-1,268
-6% -$105K 0.06% 117
2019
Q3
$1.54M Sell
20,382
-1,489
-7% -$102K 0.05% 115
2019
Q2
$1.59M Sell
21,871
-2,151
-9% -$169K 0.06% 115
2019
Q1
$1.94M Sell
24,022
-2,800
-10% -$229K 0.07% 109
2018
Q4
$2.47M Sell
26,822
-1,150
-4% -$101K 0.1% 100
2018
Q3
$2.65M Buy
27,972
+151
+0.5% +$14.3K 0.1% 99
2018
Q2
$2.58M Sell
27,821
-1,934
-6% -$189K 0.1% 99
2018
Q1
$2.82M Sell
29,755
-761
-2% -$83.6K 0.11% 97
2017
Q4
$2.95M Sell
30,516
-450
-1% -$42.4K 0.12% 95
2017
Q3
$2.75M Buy
30,966
+1,635
+6% +$124K 0.11% 97
2017
Q2
$2.13M Sell
29,331
-5,329
-15% -$358K 0.09% 101
2017
Q1
$2.26M Buy
34,660
+393
+1% +$24.7K 0.1% 98
2016
Q4
$2.15M Buy
34,267
+1,593
+5% +$97.2K 0.1% 101
2016
Q3
$2.06M Buy
32,674
+305
+0.9% +$19.7K 0.1% 99
2016
Q2
$2M Buy
32,369
+5,362
+20% +$327K 0.1% 98
2016
Q1
$1.54M Sell
27,007
-1,013
-4% -$56.5K 0.08% 104
2015
Q4
$1.66M Buy
28,020
+162
+0.6% +$9.33K 0.08% 103
2015
Q3
$1.52M Buy
27,858
+1,640
+6% +$107K 0.08% 111
2015
Q2
$1.76M Sell
26,218
-543
-2% -$35.4K 0.09% 103
2015
Q1
$1.57M Buy
26,761
+1,800
+7% +$109K 0.08% 104
2014
Q4
$1.63M Buy
24,961
+150
+0.6% +$9.46K 0.09% 100
2014
Q3
$1.43M Sell
24,811
-1,000
-4% -$55.5K 0.08% 100
2014
Q2
$1.46M Buy
25,811
+1,054
+4% +$55.3K 0.08% 100
2014
Q1
$1.27M Sell
24,757
-3,203
-11% -$162K 0.08% 103
2013
Q4
$1.48M Buy
27,960
+350
+1% +$17.2K 0.09% 98
2013
Q3
$1.24M Sell
27,610
-150
-0.5% -$6.65K 0.08% 102
2013
Q2
$1.15M Buy
+27,760
New +$1.21M 0.08% 98

Other funds holding ABBV

R.M. Davis Inc's ABBV Position: Q2 2026 in Review

R.M. Davis Inc increased its AbbVie (ABBV) stake by 0.61% in Q2 2026, buying an estimated $23.5K and bringing the position to 18,009 shares worth $4.53M. The position accounts for 0.07% of the portfolio, ranked #93.

R.M. Davis Inc first reported a position in ABBV in Q2 2013 and has held it in 53 quarters since. 4,194 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • R.M. Davis Inc held 18,009 shares of AbbVie worth $4.53M as of Q2 2026.
  • R.M. Davis Inc bought 109 AbbVie shares in Q2 2026, an estimated $23.5K.
  • AbbVie made up 0.07% of R.M. Davis Inc's portfolio in Q2 2026, its #93 holding.
  • R.M. Davis Inc first reported a position in AbbVie in Q2 2013 and has held it in 53 quarters since.
  • 4,194 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on R.M. Davis Inc's 13F filing for Q2 2026, filed 14 Aug 2026.